Science

Stem cells

Replacing or reactivating the cells that rebuild tissue.

What it is

iPSC-derived therapies have matured into manufactured, off-the-shelf products in defined indications. Longevity relevance depends on manufacturing cost and immune compatibility rather than novel biology.

Key mechanisms and technologies

iPSC differentiation
Off-the-shelf cell manufacturing
Progenitor modulation

Published LONGEFI developments are listed chronologically in the News archive.